|
|
| Line 1: |
Line 1: |
| '''One day: Thursday, September 13, 2018, 8:30 am - 4:00 pm ?'''
| |
|
| |
|
| Perhaps 5 1/2 total hours of presentations.
| | '''Successfully occurred on Thursday September 13, 2018''' |
| | |
| = Draft Agenda =
| |
| | |
| == Introduction and Overview of TOPMed data resources and services (30 minutes) ==
| |
| | |
| ''Goncalo Abecasis will present overview of IRC activies'' | |
| | |
| * Introduce IRC personnel and their expertise
| |
| * Sequence for 130,000+ participants
| |
| * Variant calls and genotypes, phased and unphased
| |
| * Structural variant calls in progress
| |
| * BRAVO variant browser
| |
| * ENCORE analysis server
| |
| * TOPMed imputation reference panel
| |
| * Main developments in the past year, including security improvements, Manual, etc.
| |
| | |
| == Characteristics of variants in data freeze 6 (20 minutes) ==
| |
| | |
| ''Hyun Min Kang and Jonathan LeFaive will present this section''
| |
| | |
| * Overall numbers
| |
| * Differences by ancestry, study and sequencing center
| |
| * Allele frequencies of deleterious variants
| |
| * Genotype accuracy
| |
| * Compare harmonized versus sequencing center mappings
| |
| * Process for variant calling, genotyping, filtering, phasing and distribution
| |
| * Process for interim 'snapshot' genotypes
| |
| | |
| == Calling structural variants (20 minutes) ==
| |
| | |
| ''Our colleagues at Baylor will present this section. William Salerno?''
| |
| | |
| * Procedures and plans for structural variant calling
| |
| * Benefits of ensemble approach
| |
| * Initial results
| |
| * Data access mechanisms
| |
| * Anticipated data size
| |
| * Coordination with SNPs and indels
| |
| | |
| == BRAVO variant browser helps to assess variant quality (20 minutes) ==
| |
| | |
| ''Daniel Taliun will present this section''
| |
| | |
| * Purpose
| |
| * Which studies are included
| |
| * Usage / main features
| |
| * Both rare and common variants
| |
| * Improvements in the last year
| |
| * Access via an applications programming interface (API)
| |
| * View all information used in filtering
| |
| * Coordination with gnomAD
| |
| * Potential plans for PheWeb integration
| |
| | |
| == Break (30 minutes) ==
| |
| | |
| == Summary of contract spending to date (20 minutes) ==
| |
| | |
| ''Denise Bianchi and Goncalo Abecasis will present this section''
| |
| | |
| * Broad subdivisions: personnel, cloud storage, cloud computing, hardware
| |
| * Divided between Task 1 and Task 2
| |
| | |
| == Improved results from the latest TOPMed imputation panel (20 minutes) ==
| |
| | |
| ''Goncalo Abecasis will present this, unless Lukas Forer is available. Ketian Yu to prepare summaries of imputation quality''
| |
| | |
| [[Media:nhlbi.4761.imputation.accuracy.2018aug31.pptx|'''(slides)''']]
| |
| | |
| * Principle of operation
| |
| * Measuring imputation quality in different populations
| |
| * Pushing the low frequency boundary
| |
| * Improved accuracy for African American and Latino samples
| |
| * Challenges and opportunities from collaboration and integration with NIH Commons / NHLBI Stage
| |
| | |
| == Potential Population Genetics Update (20 minutes) ==
| |
| | |
| '' Check with Sebastian Zoellner''
| |
| | |
| == Cloud access to TOPMed sequence data (20 minutes) ==
| |
| | |
| ''Tom Blackwell to take the lead on this section''
| |
| | |
| [[Media:nhlbi.4768.fusera.slides.01.pdf|'''(slides)''']]
| |
| | |
| * NCBI's 'Fusera' controlled access mechanism
| |
| * User perspective -- involves a Google or Amazon billing project
| |
| * What is needed for users to have a great overall experience?
| |
| * Education and training for users
| |
| | |
| == Lunch (70 minutes) ==
| |
| | |
| == ENCORE analysis server (20 minutes) ==
| |
| | |
| ''Matthew Flickinger will present this section''
| |
| | |
| * Principle of operation
| |
| * Releases only aggregate data summaries
| |
| * Visualizations help to assess results
| |
| * Data sharing and collaboration tools
| |
| * Capability to re-run previous jobs with new data
| |
| * SAIGE analysis gives accurate results in case-control studies
| |
| * Usage statistics comparing last 12-months to previous 12-months
| |
| * Some highlights from user survey results
| |
| | |
| == Manuscript support (30 minutes) ==
| |
| | |
| ''Albert Vernon Smith will present overview for this section''
| |
| | |
| * How can and how is the IRC supporting TOPMed manuscripts and discoveries?
| |
| | |
| * Overall TOPMed landmark paper
| |
| * Analysis of telomere length
| |
| * Mitochondrial DNA copy number
| |
| * Lipids analysis using TOPMed imputed genotypes
| |
| * UK BioBank with TOPMed imputation
| |
| * Context specific mutation rates
| |
| * Data sharing with Centers for Common Disease Genetics
| |
| | |
| == Interactions with outside groups (30 minutes) ==
| |
| | |
| ''Albert Vernon Smith to take the lead on this section''
| |
| | |
| * NIH Data Commons
| |
| * NHLBI Data STAGE
| |
| * NHGRI Centers for Common Disease Genetics
| |
| * Global Alliance for Genomics and Health (GA4GH)
| |
| * NIMH Parkinsons Disease Consortium
| |
| | |
| == Break (20 minutes) ==
| |
| | |
| == Future plans for the next Task Order (30 minutes) ==
| |
| | |
| == Feedback from NHLBI (40 minutes) ==
| |
| | |
| == Finish (3:50 pm) ==
| |
Successfully occurred on Thursday September 13, 2018
